Community Health Worker Support for Preeclampsia
(AW2H Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment Community Health Worker Intervention for preeclampsia?
Is the Community Health Worker Support for Preeclampsia generally safe for humans?
How does the Community Health Worker Intervention treatment for preeclampsia differ from other treatments?
The Community Health Worker Intervention for preeclampsia is unique because it involves community health workers who engage with the community to provide early diagnosis, stabilization, and referral for women with preeclampsia, especially in low-resource settings. This approach focuses on task-sharing and building trust-based relationships, which is different from traditional medical treatments that rely solely on healthcare facilities and professionals.12468
What is the purpose of this trial?
United States maternal mortality and preterm birth rates are among the highest among high-income countries due in part to a combination of racial, regional and socioeconomic disparities in access to care and overall health. The research proposed focuses on adapting and expanding a perinatal community health worker intervention for Black postpartum patients with preeclampsia (PE) and other adverse pregnancy outcomes (APOs). Investigators will partner with a community-based organization that trains and deploys community health workers. Investigators will test an intervention for urban and rural Black postpartum patients with APOs to 1) enhance blood pressure control postpartum and 2) promote long-term cardiovascular disease prevention for this underserved population. This pilot study will determine if randomizing and implementing a community health worker intervention tailored to pregnant people experiencing preeclampsia is feasible and found to be acceptable by participants.
Research Team
Jesse E Rattan
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for Black individuals between the ages of 16-56 who are experiencing adverse pregnancy outcomes like preeclampsia, preterm birth, and others. Participants must be planning to deliver at UAB Hospital, speak and write English, and not be due for delivery at enrollment.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive cardiovascular disease prevention education and community health worker support
Follow-up
Participants are monitored for satisfaction and health outcomes, including blood pressure and primary care visit scheduling
Treatment Details
Interventions
- Community Health Worker Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator
American Heart Association
Collaborator
National Institutes of Health (NIH)
Collaborator